|MR Spectroscopy of Brain
|1130. Assessing the Age-Dependent Profile in the Frontal and Centrum Semiovale Regions of Healthy Normal Controls Using In Vivo ³¹P MRS, J.A. Stanley, N.J. Minshew, M.S. Keshavan, K. Panchalingam, McClure and J.W. Pettegrew, University of Pittsburgh, Pittsburgh, PA, USA.|
|1131. Metabolite Content in Cerebral Grey and White Matter Studied with Short-Echo Time ¹H-MRSI, M.A. McLean, F.G. Woermann, P.A. Bartlett, G.J. Barker and J.S. Duncan, National Society for Epilepsy Bucks, Chalfont St. Peter, UK and University College London, London, UK.|
|1132. Cerebral Metabolite Changes Across the Menstrual Cycle in Women with PMDD and Controls.
A Preliminary Report, K. Yue, N. Rasgon, M.A. Thomas, B. Guze, L. Fairbanks, J. Curran and A. Rapkin, University of California, Los Angeles, CA, USA.
|1133. ¹H Chemical Shift Imaging Demonstration of Coherent Change in Brain Metabolism in Healthy Elderly Women Reexamined After Four Years, P.E. Sijens, T. den Heijer, A. Hofman, M.M.B. Breteler and M. Oudkerk, University Hospital Rotterdam and Erasmus University Medical School, Rotterdam, The Netherlands.|
|1134. Observation of Label Accumulation at Glutamate/Flutamine C1,2,3,4 and HCO3- in Human Brain After Intravenous 1-¹³C Labeled Glucose Infusion, S. Blüml, A. Moreno, J-H. Hwang and B.D. Ross, Huntington Medical Research Institutes, Pasadena, CA, USA and Rudi Schulte Research Institutes, Santa Barbara, CA, USA.|
|1135. Detection of 4-Phenylbutyrate in the Human Brain by In Vivo Proton MR Spectroscopy, P.B. Barker, D. Artemov, G.V. Raymond, A. Horská and H.W. Moser, Johns Hopkins University and Kennedy-Krieger Institute, Baltimore, MD, USA.|
|1136. Dynamic Modeling of Compartmental Brain Lactate Response to Metabolic Challenge: A Feasibility Study, S.D. Friedman, S.R. Dager, T. Richards, H. Petropoulos and S. Posse, University of Washington School of Medicine, Seattle, WA, USA; University of New Mexico, Albuquerque, NM, USA and Center for MR Research, Jülich, Germany.|
|1137. Increased Brain Choline Level Observed After Choline Bitartrate Ingestion, Y. Ke, N. Lange, P.F. Renshaw, S.M. Babb, M.Q. Yang, M. Kaufman, D.A. Yurgelun-Todd, A.L. Stoll and B.M. Cohen, McLean Hospital, Harvard Medical School, Belmont, MA, USA.|
|1138. ¹H MRS, MRI and Neuropsychological Testing of Patients with Traumatic Brain Injury at Long Elapsed Time since Injury, E. Brief, R. Vernon-Wilkinson, A.L. MacKay, A. Scamvougeras, H. Feldman and B. Forster, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada.|
|1139. Altered Metabolite Profile In Normal Appearing Brain Following Traumatic Brain Injury:
A Phosphorus MRS Study, M.R. Garnett, R.G. Corkill, T.A.D. Cadoux-Hudson, A.M. Blamire, B. Rajagopalan, J.D. Young and P. Styles, University of Oxford and Oxford Radcliffe Hospitals, Oxford, UK.
|1140. Evaluation of the Traumatic Brain Injured Patients in Correlation with Functional Status in Rehabilitation Medicine by Localized ¹H MR Spectroscopy, S.J. Yoon, J.H. Lee, S.T. Kim and M.H. Chun, Asan Medical Center, University of Ulsan College of Medicine and Asan Institute for Life Sciences, Seoul, Korea.|
|1141. Changes in the ¹H MR Spectra of Epileptogenic Lesions Treated with the Leksell Gamma Knife (LGK). Results from a Three Year Period, M. Hájek, M. Dezortová, R. Lièák, J. Vymazal and V. Vladyka, Homolka Hospital, Prague, Czech Republic.|
|1142. ¹H-MRS and Diffusion-Weighted Imaging Correlated to Behavioral Studies in Huntington's Disease, F.A. Barrios, A.O. Rodriguez, R. Rojas, J. Fernández, M. Alonso, G. Reynoso and J. Sánchez-Cortazar, UNAM, Queretaro, Mexico; ABC Hospital and INNN, SSA, Mexico City, Mexico.|
|1143. Hippocampal ¹H-MRSI in Ecstacy Users, T. Obergriesser, G. Ende, D.F. Braus, W. Weber-Fahr and F.A. Henn, Central Institute of Mental Health, Mannheim, Germany.|
|1144. Intracranial Tuberculomas: Atypical MRI and MRS Findings, R.P. Tripathi, S.S. Kumaran, S. Gupta, S. Khushu, A.K. Gupta and A.K. Balwant, Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, India.|
|1145. Utility of Single Voxel MR Spectroscopy of Cerebral Lesions in AIDs, P. Corr, A. Moodley, V. Patel and A. Bhigee, Wentworth Hospital & University of Natal, Durban, South Africa.|
|1146. Proton MRSI in HIV+ Patients; Effect of Highly Active Anti-Retroviral Therapy, P.B. Barker, A. Horská, N. Sacktor, J.C. McArthur and M.G. Pomper, Johns Hopkins University, Baltimore, MD, USA.|
|1147. High Resolution ¹H NMR Analysis of Cerebrospinal Fluid: Applications to Diseases Affecting the Brain, H. Parkes, G. Guillet, E. Thompson, R. Surtees and D. Gadian, University College London Medical School, London, UK; Ecole Polytechnique, Paris, France and University College London, London, UK.|
Return to ISMRM program